U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
Immunoglobulin G1 [de-450-lysine], anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal BL-M07D1 ?1-chain), complex with human-Mus musculus monoclonal BL-M07D1 ?-chain, dimer, 214??,214???,223,223?,229,229?,232,232?-octakis(t
Preferred Name English
Trastuzumab brengitecan
INCI  
Official Name English
immunoglobulin G1-kappa, anti-[Homo sapiens ERBB2 (receptor tyrosine-protein kinase erbB-2, epidermal growth factor receptor 2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)], humanized monoclonal antibody, conjugated to a camptothecin derivative
Common Name English
trastuzumab brengitecan [INN]
Common Name English
Code System Code Type Description
INN
12677
Created by admin on Wed Apr 02 17:54:35 GMT 2025 , Edited by admin on Wed Apr 02 17:54:35 GMT 2025
PRIMARY
FDA UNII
5MHN3G4T8J
Created by admin on Wed Apr 02 17:54:35 GMT 2025 , Edited by admin on Wed Apr 02 17:54:35 GMT 2025
PRIMARY
CAS
2761149-81-7
Created by admin on Wed Apr 02 17:54:35 GMT 2025 , Edited by admin on Wed Apr 02 17:54:35 GMT 2025
PRIMARY
NCI_THESAURUS
C203071
Created by admin on Wed Apr 02 17:54:35 GMT 2025 , Edited by admin on Wed Apr 02 17:54:35 GMT 2025
PRIMARY
SMS_ID
300000054846
Created by admin on Wed Apr 02 17:54:35 GMT 2025 , Edited by admin on Wed Apr 02 17:54:35 GMT 2025
PRIMARY